entertainment -WSS

entertainment

author：comprehensive 2025-10-06 17:54:31 - browse：4

After earning her doctorate in cell biology at the University of Pennsylvania in June, Sierra Collins did what many freshly minted Ph.D.s. do — she went looking for a job at a biotech company. But what was supposed to be a straightforward search has turned into an odyssey.

Collins has applied for more than 53 positions (and counting). Like a good scientist, she’s gathering data along the way and uses a spreadsheet to track each company’s size and therapeutic focus, as well as whether she was referred for the position and how far she made it through the application process. So far, those efforts have been unsuccessful.

“I try my best not to take it personally. These are companies that are trying to find an employee who’s going to help them achieve their business goals,” Collins said. “But it is pretty discouraging just repeatedly getting turned down, especially at later stages of the interview process.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Why the advice to take all your antibiotics may be wrong

explore

WSS

Sanofi CEO defends move to abandon profit guidance, boost research

Pfizer's RSV vaccine recommended for approval in Europe

The new shift in health care is toward less care

HPV cancer vaccine study demonstrates efficacy

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Removing probiotics from the NICU could threaten preemies' health

hotspot

entertainment

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

UCSF medical school apologizes for unethical prisoner experiments

Novavax promises a turnaround & Lilly roils the obesity market

UCSF medical school apologizes for unethical prisoner experiments

Psychedelics group wrestles with new pharma identity

The biotech scorecard for the 2nd quarter: 12 industry events to watch

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Executive Editor Rick Berke on STAT's 8th birthday

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Executive Editor Rick Berke on STAT's 8th birthday

leisure time

Pfizer's RSV vaccine recommended for approval in Europe

FDA approves Recor Medical high blood pressure device

Listen: BridgeBio's big week & Lilly's Alzheimer's data

What is artificial intelligence? Experts weigh in

Biotech incubator Curie.Bio graduates its first startup

White House calls on federal agencies to crack down on AI abuses

explore

focus

focus

focus